Response to Standard PBC Treatment at 1 Year Linked to Lower Long-Term Risks
Summary
(MedPage Today) -- A biochemical response to ursodeoxycholic acid (UDCA) at 12 months was associated with lower 5-year risks of hepatic decompensation and mortality in patients with primary biliary cholangitis (PBC), a propensity-matched landmark...
Description from Medpagetoday.
Who is covering this
-
Response to Standard PBC Treatment at 1 Year Linked to Lower Long-Term Risks
(MedPage Today) -- A biochemical response to ursodeoxycholic acid (UDCA) at 12 months was associated with lower 5-year risks of hepatic decompensation and mortality in patients with primary biliary cholangitis (PBC), a propensity-matched landmark...
Comments
Comments need JavaScript.